Basket - Other
RYZ211-001
A Phase 0 Imaging Study to Assess the Feasibility, Biodistribution, and Dosimetry of a Trophoblast Cell Surface Antigen 2 (TROP2) Binder in Metastatic Urothelial Cancer (UC), Hormone Receptor–Positive (HR+) and Human Epidermal Growth Factor Receptor 2–Negative (HER2–) Breast Cancer, Triple-Negative Breast Cancer (TNBC), and Non-Small-Cell Lung Cancer (NSCLC).
Trial overview
Clinical Area
Theranostics
Disease
Basket
Disease site
Basket
Study Phase
0
Trial Identifiers
Registration number: NCT07671092
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries